epilepsy

  • Warning: array_map(): Argument #2 should be an array in system_region_list() (line 1020 of /drive/system/code/drupal6/drupal/modules/system/system.module).
  • Warning: array_keys() expects parameter 1 to be array, null given in template_preprocess_page() (line 1847 of /drive/system/code/drupal6/drupal/includes/theme.inc).
  • Warning: Invalid argument supplied for foreach() in template_preprocess_page() (line 1847 of /drive/system/code/drupal6/drupal/includes/theme.inc).

Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.

Miller AD, Krauss GL, Hamzeh FM. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine. Acta Neurol Scand. 2004;109(6):374-7. DOI: 10.1111/j.1600-0404.2004.00291.x. PubMed PMID: 15147458.

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia. 2008;49(7):1123-41. DOI: 10.1111/j.1528-1167.2008.01665.x. PubMed PMID: 18503564.

Clinical pharmacology of antiepileptic drugs.

Bazil CW, Pedley TA. Clinical pharmacology of antiepileptic drugs. Clin Neuropharmacol. 2003;26(1):38-52. PubMed PMID: 12567163.

Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet. 2002;41(8):559-79. DOI: 10.2165/00003088-200241080-00002. PubMed PMID: 12102641.

Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.

Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin Pharmacokinet. 2013;52(11):927-66. DOI: 10.1007/s40262-013-0087-0. PubMed PMID: 23784470.

Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?

Johannessen SI, Tomson T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?. Clin Pharmacokinet. 2006;45(11):1061-75. DOI: 10.2165/00003088-200645110-00002. PubMed PMID: 17048972.

The use of antiepileptic drugs--principles and practice.

Sander JW. The use of antiepileptic drugs--principles and practice. Epilepsia. 2004;45 Suppl 6:28-34. DOI: 10.1111/j.0013-9580.2004.455005.x. PubMed PMID: 15315513.

Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies.

Benedetti MS. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol. 2000;14(4):301-19. PubMed PMID: 11030437.

Lamotrigine clearance during pregnancy.

Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R. Lamotrigine clearance during pregnancy. Neurology. 2002;59(2):251-5. PubMed PMID: 12136066.

Letter: Recruitment of patients with both epilepsy and intellectual disability.

van Mierlo P, Snoeijen-Schouwenaars FM, Veendrick MJBM, Tan IY, Willemsen MH, Schelhaas HJ, et al. Letter: Recruitment of patients with both epilepsy and intellectual disability. Epilepsia. 2015;56(4):662-3. DOI: 10.1111/epi.12948. PubMed PMID: 25868091.
Syndicate content